ionophore A-23187, which depletes the intracellular store sites, elevated DAF-2 fluorescence in both control and high D-glucose-treated cells in Ca 2ϩ -free solution. These results indicate that glucose overload impairs NO production by the O 2 Ϫ -mediated attenuation of Ca 2ϩ entry.
calcium; superoxide; diaminofluorescein 2 CARDIOVASCULAR DISEASE, including coronary heart disease, stroke, and peripheral vascular disease, is the most important cause of mortality and morbidity among patients with diabetes mellitus (1, 15, 31) , in which impairment of endothelial functions may be involved (19) . As vascular endothelium plays its physiological roles by producing various mediators, including nitric oxide (NO) (23) , the production of these endothelium-derived substances might be impaired in hyperglycemic conditions. This idea is supported in a previous report, showing that the aortic ring from diabetic rabbit failed to induce endothelium-derived relaxation in response to acetylcholine (34) . Accumulation of superoxide anion (O 2 Ϫ ) is one of the reported candidates for the pathogenesis of vascular and/or endothelial damage in a diabetic environment. Excess glucose causes autooxidation of glucose and nonenzymatic protein glycation, both of which generate O 2 Ϫ (40) . Metabolism of excess D-glucose via its collateral pathway, the polyol pathway, increases the NADH/NAD ϩ ratio, which results in the activation of protein kinase C and phospholipase A 2 . Prostaglandins are then synthesized by cyclooxygenase, which is capable of generating O 2 Ϫ as an intermediate (34, 39) . Fructose, a product of the polyol pathway, also generates O 2 Ϫ , because it induces protein glycation more efficiently than glucose (33) . Furthermore, it has been reported that the activity of endogenous superoxide dismutase (SOD) is suppressed by hyperglycemia due to glycation (2) . We have previously shown (12) (24) . Therefore, our previous findings raise a question that needs to be clarified, i.e., whether these impairments of Ca 2ϩ homeostasis are responsible for the attenuation of endothelium-derived vasodilatation in the hyperglycemic condition.
For the measurement of cellular NO production, direct measurement of released NO by porphyrinic microsensor (20) or measurement of its metabolite, nitrite, by the Griess method (38) has been used. Diaminofluorescein 2 (DAF-2) has been developed recently as an NO-sensitive fluorescent dye, whose fluorescence was shown to correlate with the NO concentration from submicromolar levels (14) . Furthermore, intracellular production of NO has been measured successfully from living cells by use of a membrane-permeable form of DAF-2, diacetylated DAF-2 (DAF-2/ DA), in rat aortic smooth muscle cells (14) and BAEC (11) . The major advantage of using DAF-2 is that it enables the measurement of intracellular NO production from living cells after any arbitrary pretreatment of the cell, including glucose overload.
We examined the characteristics of cellular NO production in hyperglycemic conditions in BAEC by using DAF-2. In the present study, we used ATP to induce NO production in BAEC. We recently reported (27) that ATP is released from BAEC in response to mechanical stress. Because vascular endothelium shows its various physiological functions autonomically in response to mechanical stress (5), we supposed that ATP-induced cellular responses play an important role in endothelial physiology. The results obtained indicate that glucose overload attenuates endothelial NO production, and that this can be attributed mainly to the O 2 Ϫ -mediated impairment of Ca 2ϩ mobilization that we previously clarified.
METHODS

Culture of BAEC.
Bovine thoracic aorta of 1-yr-old calf was obtained from the local slaughterhouse. Endothelial cells were scraped off from the intima with the edge of a razor. Collected endothelial cells were cultured in DMEM (Life Technologies, Rockville, MD) containing 10% fetal calf serum under 5% CO 2 -95% air at 37°C. Cells of a second subculture were used in the present experiment. Cells were seeded, either on coverslips for measuring [Ca 2ϩ ] i and NO production or on a 96-well culture plate for measuring O 2 Ϫ generation, and were cultured for Ն4 days after seeding. Identification of endothelial cells was confirmed by the specific uptake of acetylated low-density lipoprotein.
Measurement of [Ca 2ϩ ] i . [Ca 2ϩ ] i was measured from nonconfluent single cells by use of an Attofluor digital fluorescence microscopy system (Atto Instruments, Rockville, MD). Cells were loaded with fura 2 by incubation with 1 M fura 2-AM (Dojindo, Kumamoto, Japan) for 20 min at 37°C. Fura 2 was excited at two alternative wavelengths (340 and 380 nm), and the emitted fura 2 fluorescence images of 510-nm wavelength were recorded into a rewritable optical disc recorder (LQ-4100A, Panasonic, Osaka, Japan) at a rate of ϳ1 Hz. For each cell, fluorescence intensities excited at 340 and 380 nm (F 340 and F 380 , respectively) were calculated from each image, and these data were converted to fluorescence ratio (F 340 /F 380 ) and apparent [Ca 2ϩ ] i as previously reported (27) .
Measurement of O 2
Ϫ by MCLA. We measured the generation of O 2 Ϫ in BAEC by using an O 2 Ϫ -sensitive luciferin derivative, 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one (MCLA; Tokyo Kasei, Tokyo, Japan) (26) . Cells were cultured for 4 days on a 96-well culture plate, and the culture medium was replaced with Krebs or high-glucose Krebs solutions and incubated for 3 h. Then the solution was replaced with 50 l of 1M MCLA-containing solutions, and illuminated photons were counted for 10 min with a luminescence detection system (Argus-50/2D luminometer, Hamamatsu Photonics, Hamamatsu, Japan Fig. 2) .
Measurement of intracellular production of NO. NO was measured by use of DAF-2, an NO-sensitive fluorescent dye (14) . Cells were loaded with 10 M DAF-2/DA (Daiichi Pure Chemicals, Tokyo, Japan) for 30 min at 37°C. The DAF-2 fluorescence was measured by use of the same equipment as for [Ca 2ϩ ] i measurements but with a different filter set, i.e., excitation at 490 nm and emission at 515 nm. Because we found in the preliminary experiment that the frequent application of the excitation wavelength quenches DAF-2 fluorescence, we applied the excitation wavelength with an interval of 30 s. Therefore, temporal resolution of DAF-2 fluorescence was inevitably lower than that of [Ca 2ϩ ] i in the present study. It has been reported that DAF-2 fluorescence increases almost linearly with the NO concentration (14); therefore, we expressed the intracellular NO production as the net increment of DAF-2 fluorescence in 15 min relative to its basal value. Because NO synthase (NOS) produces O 2 Ϫ instead of NO in the absence of a sufficient concentration of L-arginine (30), we added a maximal concentration of Larginine (10 mM) to all solutions used for NO measurement, except for the experiment with N -nitro-L-arginine methyl ester (L-NAME)-treated cells. The solutions were alkalized by the addition of a high concentration of L-arginine, and we therefore readjusted the pH to 7.3 with HCl.
Drugs and solutions. The standard extracellular solution was a modified Krebs solution (1.5 mM Ca 2ϩ solution) containing (in mM): 132 NaCl, 5.9 KCl, 1.2 MgCl 2 , 1.5 CaCl 2 , 11.5 glucose, 11.5 HEPES, with pH adjusted to 7.3 with NaOH. High-glucose solution was made by replacing 6 mM NaCl with 11.5 mM D-or L-glucose, and Ca 2ϩ -free solution was made by replacing 1.5 mM CaCl 2 with 1 mM EGTA. The bath was perfused continuously with these solutions at a rate of 1.5 ml/min.
Thapsigargin and cyclopiazonic acid (CPA), inhibitors of endoplasmic Ca 2ϩ -ATPase, were used to deplete intracellular Ca 2ϩ store sites. Neomycin was used to inhibit phospholipase C. We used SOD, a scavenger of O 2 Ϫ , catalase, a scavenger of hydrogen peroxide, and deferoxamine, an inhibitor of hydroxyl radical production. A-23187, a Ca 2ϩ ionophore, was used to deplete intracellular Ca 2ϩ store sites in a nonspecific manner. Pyrogallol was used as a spontaneous generator of O 2 Ϫ due to autooxidation (21) . L-NAME was used to inhibit NOS. All of these drugs were obtained from Sigma (St. Louis, MO). All experiments were performed at room temperature (25°C).
Exposure of cells to high-glucose environment. In this study, BAEC were pretreated for 3 h with either 11.5 mM D-glucose solution (normal glucose), 23 mM D-glucose solution (high D-glucose) or 11.5 mM D-glucose ϩ 11.5 mM Lglucose solution (high L-glucose). Because a lower D-glucose concentration (5.8 mM) did not show any difference in Ca 2ϩ mobilizing properties and DAF-2 fluorescence from those treated with 11.5 mM glucose, we used 11.5 mM glucose, employed in our laboratory as normal Krebs, as "normal glucose" solution. We did not examine the chronic effects of glucose overload, because culture medium, which contains sufficient concentration of antioxidative amino acids and vitamins, would have had to be used for pretreating the cells for days, and this would have artificially reduced the impairing effects of high-glucose-induced O 2 Ϫ accumulation. Data analysis. Pooled data are given as means Ϯ SE, and statistical significance was determined with Student's unpaired t-test and one-way ANOVA for comparing two groups and more than three groups, respectively. Probabilities of Ͻ5% (P Ͻ 0.05) were regarded as significant. (Fig. 1B) , but not in high L-glucose-treated cells (not shown), ATP (1 M)-induced Ca 2ϩ oscillations were abolished. Impairment of ATP-induced Ca 2ϩ oscillations in high D-glucose-treated cells was restored by SOD (100 U/ml). However, catalase (1,200 U/ml) and deferoxamine (1 mM) did not reverse the impairment of Ca 2ϩ oscillation in high D-glucosetreated cells (not shown).
RESULTS
Effects of glucose overload on
In our previous report (12), we also showed that the abolition of Ca 2ϩ oscillations was partially due to the impairment of CRAC. Thapsigargin (1 M) induced transient [Ca 2ϩ ] i elevation in Ca 2ϩ -free solution due to store depletion (Fig. 1C) . Subsequent application of Ca 2ϩ -containing solution induced further [Ca 2ϩ ] i increase due to CRAC in control cells (Fig. 1C) . On the other hand, the CRAC phenomenon was not observed in high D-glucose-treated cells (Fig. 1D) . This was also restored by SOD but not by catalase or deferoxamine (Fig. 1E) into extracellular space by the use of MCLA (26) . As shown in Fig. 2 , the amount of O 2 Ϫ generated from BAEC after the incubation with normal glucose for 3 h was equivalent to 0.018 Ϯ 0.005 mU/ml of xanthine oxidase (n ϭ 10). In contrast, the value was significantly higher in high D-glucose (0.139 Ϯ 0.003 mU/ml; n ϭ 10) but similar in high L-glucose solution (0.020 Ϯ 0.008 mU/ml; n ϭ 10). This was completely scavenged by SOD (below the detection limit) but not by catalase or deferoxamine (Fig. 2) (Fig. 3A) . It should be noted that the reaction between DAF-2 and NO is irreversible (14); therefore, the accumulated level of DAF-2 fluorescence corresponds to the total amount of cellular NO production of the period. The ATP-induced increase in DAF-2 fluorescence was suppressed in cells pretreated with 0.1 mM L-NAME for 30 min, suggesting that DAF-2 fluorescence is linked to the cellular NO production (Fig. 3A) . ATP increased DAF-2 fluorescence in a concentration-dependent manner in both Ca 2ϩ -containing and Ca 2ϩ -free solutions (Fig. 3C) . Pretreatment with 1 mM neomycin for 30 min suppressed the 10 M ATP-induced increase in DAF-2 fluorescence in Ca 2ϩ -free solution (Fig. 3C ), thereby indicating that the increase in DAF-2 fluorescence in Ca 2ϩ -free solution was due to Ca 2ϩ release from intracellular store sites in BAEC. However, the increment of DAF-2 fluorescence was significantly smaller in Ca 2ϩ -free solution than in Krebs solution, and ATP Ͻ1 M did not induce a DAF-2 increase in Ca 2ϩ -free solution (Fig. 3C) . On the other hand, the ATP (1 and 10 M)-induced increase in DAF-2 fluorescence was significantly smaller in high D-glucose-treated cells (Fig. 3, B and C) . As in the case of Ca 2ϩ mobilization, high L-glucosetreated cells showed a normal increase in DAF-2 fluorescence (Fig. 3B) . The basal level of NO production, estimated by perfusing L-arginine alone without Ca 2ϩ -mobilizing agents for 15 min, was not different between control and high-glucose-treated cells [control, 0.017 Ϯ 0.006 (n ϭ 20); high-glucose-treated, 0.022 Ϯ 0.008 (n ϭ 18); P Ͼ 0.05].
As shown in Fig. 1 , D-glucose overload interferes with endothelial Ca 2ϩ homeostasis. We therefore further examined whether the attenuation of ATP-induced NO production by D-glucose overload is due to impairment of Ca 2ϩ homeostasis or to other factors such as the inhibition of NOS. For this purpose, we investigated the effects of D-glucose overload on NO production induced by the Ca 2ϩ ionophore A-23187, which nonselectively induces Ca 2ϩ entry from the extracellular space and Ca 2ϩ release from the intracellular store sites (18) . To avoid the involvement of CRAC, we applied A-23187 in Ca 2ϩ -free solution. Ϫ in a concentration-dependent manner (inset). **P Ͻ 0.01; n.d., not significantly different, P Ͼ 0.05; †value below the detection limit.
[Ca 2ϩ ] i response over 5 min was not different between control and high D-glucose conditions ( Fig. 4B ; P Ͼ 0.05), indicating that glucose overload does not affect the A-23187-induced store depletion. A-23187 also increased DAF-2 fluorescence in the absence of extracellular Ca 2ϩ in both normal glucose-and high D-glucosetreated cells ( Fig. 4C ; P Ͼ 0.05). This was not because A-23187 scavenged O 2 Ϫ , because MCLA chemiluminescence was not restored by A-23187 (Fig. 4D) (Fig. 1 and Ref. 12) , which is markedly accumulated in the extracellular space in the high D-glucose condition (Fig. 2) . Thus we pretreated the cells with high D-glucose solution in the presence of SOD, catalase, or deferoxamine, and we measured ATP-induced NO production. SOD-treated cells showed an increase in DAF-2 fluorescence in response to 1 M ATP similar to that in control cells (Fig. 5) . In contrast, catalase and deferoxamine did not restore the glucose overload-induced attenuation of NO production (Fig. 5) .
We then examined the effects of exogenously applied O 2 Ϫ on ATP-induced NO production. For this purpose, cells were treated for 30 min at 37°C with 200 M pyrogallol. Control cells treated with Krebs solution for the same period showed Ca 2ϩ oscillations in response to 1 M ATP (Fig. 6A) . However, in pyrogallol-treated cells, ATP showed a [Ca 2ϩ ] i increase with a single peak but no Ca 2ϩ oscillations (Fig. 6B) , as in the case of high D-glucose-treated cells (Fig. 1B) ] i-CRAC ) were also suppressed in pyrogallol-treated cells (not shown). Furthermore, 1 M ATP did not show any apparent increase in DAF-2 fluorescence (Fig. 6C) .
These results suggest that the generation of O 2 Ϫ is responsible for the impairment of NO production in the high D-glucose condition.
DISCUSSION
Many investigators have reported that the highglucose condition attenuates endothelium-derived vasorelaxation (7, 22, 29, 35) . Therefore, it has been speculated that glucose overload would cause the impairment of NO release and/or the increased destruction of released NO. Langenstroer and Pieper (16) reported that the resting level of NO release was rather increased in diabetic rat aorta but that the endothelial functions were nevertheless attenuated Ϫ to generate peroxynitrite (9) . The present results indicate that the production of NO is also impaired by acute glucose overload in BAEC due to the O 2 Ϫ -induced attenuation of Ca 2ϩ mobilization. The impairing effects of glucose overload are not due to the nonspecific action of glucose but to the metabolism of excess glucose, because nonmetabolizable L-glucose did not show an inhibitory effect on DAF-2 fluorescence (Fig. 3B) . We measured the intracellular NO production induced by ATP and A-23187 with DAF-2; therefore, it should be noted that the present results did not take into account the possible destruction of released NO by O 2 Ϫ . It should also be noted that the present study was performed with the use of cultured endothelial cells, whose properties may not be identical to those in vivo, and DAF-2 fluorescence may have been influenced by dye quenching. Furthermore, the present study did not investigate the possible involvement of other cellular changes, such as the activation of protein kinase C (13) and the polyol pathway (3) in glucose overload-induced endothelial dysfunction.
Cosentino et al. (4) reported that long-term incubation of human endothelium with 22.2 mM glucose for 5 days increased the expression level of endothelial NOS mRNA and ionomycin-induced nitrite production. However, we consider that this does not contradict the present results, because the agonist-induced Ca 2ϩ mobilizing pathways were bypassed by use of the Ca 2ϩ ionophore ionomycin in their report. Actually we observed that A-23187-induced NO production was not affected by glucose overload (Fig. 4) . Therefore, although agonist-induced, Ca 2ϩ -dependent NO production requires CaM and NOS (24), we suppose that the attenuation of NO production by acute glucose overload can be attributed to the impairment of Ca 2ϩ homeostasis but not to the alteration of these molecules. We have shown that glucose overload abolishes Ca 2ϩ oscillations ( Fig. 1 entry from the extracellular space, and reloading of the intracellular Ca 2ϩ store sites (32) . Therefore, although 1 M ATP induced Ca 2ϩ transient in high glucosetreated cells also (Fig. 1B) , the fact that Ca 2ϩ oscillations were abolished would indicate that some of the Ca 2ϩ mobilizing pathways were impaired. Because we observed that CRAC was attenuated by glucose overload (Fig. 1, D and E) , we suppose that at least the (17) reported that, in human umbilical cord vein endothelial cells, NO production is triggered by Ca 2ϩ entry from the extracellular space but not by Ca 2ϩ release from store sites. The authors speculated that this was due to the submembrane localization of endothelial NOS. We also observed that ATP-induced NO production was much larger in the Ca 2ϩ -containing solution than in the Ca 2ϩ -free solution (Fig. 3C ), suggesting the preferential production of NO by entered Ca 2ϩ , especially in the case of low levels of stimulation. However, considerable elevation of DAF-2 fluorescence was also induced by a high concentration of ATP or A-23187 in Ca 2ϩ -free solution, thereby indicating that depletion of the intracellular Ca 2ϩ store sites leads to NO production in BAEC. As shown in Fig. 4C , store depletion-induced NO production was not inhibited by glucose overload. Therefore, we hypothesized that the impairment of CRAC plays a central role in the attenuation of ATP-induced NO production by acute D-glucose overload. This is not selective for ATPinduced NO production, since glucose overload also attenuated 0.3 M ACh-induced NO production (C. Kimura and M. Oike, unpublished observation).
A high-glucose environment leads to the accumulation of O 2 Ϫ , as summarized in the introductory section. In the present experiment, SOD, but not catalase or deferoxamine, restored high-glucose-induced impairment of Ca 2ϩ homeostasis ( Fig. 1 ) and NO production (Fig. 5) . Furthermore, we confirmed the impairing effects of O 2 Ϫ on Ca 2ϩ homeostasis and NO production by pretreating the cell with pyrogallol (Fig. 6) . Therefore, we conclude that O 2 Ϫ , which affects Ca 2ϩ homeostasis, is responsible for the impairment of NO production in the hyperglycemic condition. Using MCLA chemiluminescence, we confirmed that the high D-glucose condition induces the increased generation and/or decreased scavenging of O 2 Ϫ , which was abolished by SOD (Fig. 2) . MCLA is a water-soluble substance that does not permeate the cell membrane (25) , and MCLA chemiluminescence was not detected in cell-free culture wells (Fig. 2) . Therefore, although O 2 Ϫ is supposed to be generated inside the cell as a result of glucose metabolism, it seems that O 2 Ϫ permeates the membrane and is released into the extracellular space and then affects Ca 2ϩ pathways of the cell and/or neighboring cells. We suppose that this is why SOD, a large molecule (31 kDa) that could not penetrate the cell membrane, scavenged the intracellularly generated O 2 Ϫ and restored Ca 2ϩ mobilization and NO production. Graier et al. (10) reported that the high-glucose-induced generation of O 2 Ϫ enhanced endothelium-derived relaxing factor formation in porcine aortic endothelium. They incubated the cells for 24 h with a high-glucose culture medium and observed that bradykinin-induced Ca 2ϩ transient and cGMP concentration were augmented in high-glucose-treated cells due to O 2 Ϫ production. However, the present study and many reports from other laboratories (7, 22, 28, 35) indicate that glucose overload attenuates endothelium-derived relaxation or NO production. Although it may be possible that this discrepancy was due to the differences in the period of glucose overload, species, and agonist, we could not identify the precise reason for the discrepancy.
It is well known that the impairment of endothelial constitutive NO production would result not only in the loss of local control of vascular tonus but also in the development of atherosclerosis (36) , heart failure (6), or cerebrovascular events (37) . Therefore, the mechanism shown in the present study is probably involved in the pathogenesis of some diabetic vascular complications. In conclusion, we have shown that acute glucose overload attenuates endothelial NO production by the impairment of Ca 2ϩ homeostasis, especially CRAC. Our results also suggest that scavenging O 2 Ϫ might be a good therapeutic approach to diabetic vascular complications.
